$AVGR: NEWS!! Avinger Announces 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease
http://www.otcmarkets.com/stock/AVGR/news
(1)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.